Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

LeMaitre Vascular stock hits 52-week low at 73.54 USD

LeMaitre Vascular stock hits 52-week low at 73.54 USD

LeMaitre Vascular Inc's stock hit a 52-week low of $73.54, marking a 37% drop from its peak of $118.01. Despite this, analysts believe the company could be undervalued, with a Fair Value estimate exceeding the current trading price. The stock's decline comes after a 15.74% decrease over the past year. Four analysts have recently lowered their earnings forecasts for the upcoming period.

However, LeMaitre Vascular holds a solid financial health score of 3.18 and more cash than debt on its balance sheet. The medical device manufacturer has faced scrutiny amid broader market conditions and company-specific challenges. In their third-quarter earnings report, LeMaitre Vascular reported $68 million in revenue, surpassing estimates, but its adjusted earnings per share fell short, coming in at $0.65 versus the expected $0.69.

Wells Fargo and Citizens revised their price targets for the company following the results. Wells Fargo lowered its target to $86 with an Equal Weight rating due to a margin miss, while Citizens reduced its target to $110 with a Market Outperform rating. The company's revenue grew 9% year-over-year in the Americas and 17.5% in international markets, excluding foreign exchange impacts.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Other reports of this story

Every outlet that reported this, and when →

Read the original at investing.com →

More in Finance & Markets

More from Friday 20 November →